Share-Based Compensation | Note 12. Share-based Compensation Farmer Bros. Co. Amended and Restated 2017 Long-Term Incentive Plan (the “2017 Plan”) As of December 31, 2024, there were 1,081,654 shares available under the 2017 Plan including shares that were forfeited under the prior plans for future issuance. Farmer Bros. Co. 2020 Inducement Incentive Award Plan (the “2020 Inducement Plan”) As of December 31, 2024, there were 2,919 shares available under the 2020 Inducement Plan. Non-qualified stock options with time-based vesting (“NQOs”) One-third of the total number of shares subject to each stock option vest ratably on each of the first three anniversaries of the grant date, contingent on continued employment, and subject to accelerated vesting in certain circumstances. There were no NQOs granted, exercised, cancelled or forfeited during the six months ended December 31, 2024. As of December 31, 2024, there were 19,450 NQOs exercisable and outstanding with a weighted average remaining life of 1.7 years. The weighted average exercise price of NQO’s was $17.75. The NQOs have an intrinsic value of zero at December 31, 2024. Restricted Stock The following table summarizes restricted stock activity for the six months ended December 31, 2024: Outstanding and Nonvested Restricted Stock Awards: Shares Weighted Average Outstanding and nonvested at June 30, 2024 662,661 3.72 Granted 410,000 2.22 Vested/Released (138,559) 3.77 Cancelled/Forfeited (37,291) 3.20 Outstanding and nonvested at December 31, 2024 896,811 3.05 The weighted average grant date fair value of RSUs granted during the quarter ended December 31, 2024 and 2023 were $2.13 and $2.42, respectively. The total grant-date fair value of restricted stock granted during the six months ended December 31, 2024 was $0.9 million. The total fair value of awards vested during the six months ended December 31, 2024 and 2023 were $0.5 million and $0.6 million, respectively. At December 31, 2024 and June 30, 2024, there was $1.7 million and $1.7 million, respectively, of unrecognized compensation cost related to restricted stock. The unrecognized compensation cost related to restricted stock at December 31, 2024 is expected to be recognized over the weighted average period of 1.3 years. Total compensation expense for restricted stock was $0.3 million and $0.4 million, respectively, in the three months ended December 31, 2024 and 2023. Total compensation expense for restricted stock was $0.7 million and $1.0 million, respectively, in the six months ended December 31, 2024 and 2023. Performance-Based Restricted Stock Units (“PBRSUs”) The following table summarizes PBRSU activity for the six months ended December 31, 2024: Outstanding and Nonvested PBRSUs: PBRSUs Weighted Average Outstanding and nonvested at June 30, 2024 394,576 2.95 Granted 530,000 2.21 Vested/Released — — Cancelled/Forfeited (45,000) 2.42 Outstanding and nonvested at December 31, 2024 879,576 2.53 The weighted average grant date fair value of PBRSUs granted during the quarter ended December 31, 2024 and 2023 was $2.21 and $2.42, respectively. The total grant-date fair value of PBRSU granted during the six months ended December 31, 2024 was $1.2 million. There were no PBRSU’s vested during the six months ended December 31, 2024. The total fair value of awards vested during the six months ended December 31, 2023 was $0.3 million , respectively . At December 31, 2024 and June 30, 2024, there was $1.4 million and $0.9 million, respectively, of unrecognized PBRSU compensation cost. The unrecognized PBRSU compensation cost at December 31, 2024 is expected to be recognized over the weighted average period of 2.2 years . Total compensation expense for PBRSUs was $0.2 million and $22 thousand , respectively, for the three months ended December 31, 2024 and 2023 . Total compensation expense for PBRSUs was $0.4 million and $0.2 million , respectively, for the six months ended December 31, 2024 and 2023 . Cash-Settled Restricted Stock Units (“CSRSUs”) CSRSUs vest in equal installments over a three-year period from the grant date, and are cash-settled upon vesting based on the closing share price of Common Stock on the vesting date. The CSRSUs are accounted for as liability awards, and compensation expense is measured at fair value on the date of grant and recognized on a straight-line basis over the vesting period net of forfeitures. Compensation expense is remeasured at each reporting date with a cumulative adjustment to compensation cost during the period based on changes in the closing share price of Common Stock. The following table summarizes CSRSU activity for the six months ended December 31, 2024: Outstanding and Nonvested CSRSUs: CSRSUs Weighted Average Outstanding and nonvested at June 30, 2024 619,327 2.94 Granted 602,000 2.13 Vested/Released (211,673) 3.27 Cancelled/Forfeited (35,291) 3.24 Outstanding and nonvested at December 31, 2024 974,363 2.36 The weighted average grant date fair value of CRSUs granted during the quarter ended December 31, 2024 and 2023 was $2.13 and $2.42, respectively. The total grant-date fair value of CRSU granted during the six months ended December 31, 2024 was $1.3 million. The total fair value of awards vested was $0.4 million and $0.2 million during the six months ended December 31, 2024 and 2023, respectively. At December 31, 2024 and June 30, 2024, there was $1.6 million and $1.6 million, respectively, of unrecognized compensation cost related to CSRSU. The unrecognized compensation cost related to CSRSU at December 31, 2024 is expected to be recognized over the weighted average period of 1.7 years. Total compensation expense for CSRSUs was $0.2 million and $0.1 million, respectively for the three months ended December 31, 2024 and 2023. Total compensation expense for CSRSUs was $0.4 million and $0.2 million, respectively for the six months ended December 31, 2024 and 2023. |